Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Global Request for Proposals – Pfizer Clostridioides difficile (C. difficile) Research CollaborationRelease Date:Call for Collaborator(s) Vaccines France, Germany Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Title Grant Type Focus Area Country Application Due Date Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory ConditionsRelease Date:Review Process:Improving the Clinical Management of Uncontrolled AcromegalyRelease Date:Review Process:Antimicrobial Stewardship in the Asia-Pacific RegionRelease Date:Review Process:Lysosomal Storage Disorders Fellowship for Nurse PractitionersRelease Date:Review Process:Hemophilia PUP RegistryRelease Date:Review Process:Quality Improvement Initiatives:Improving Screening and Diagnosis of Atrial Fibrillation and Optimizing Treatment and ManagementRelease Date:Review Process:Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory ConditionsRelease Date:Review Process:Accelerating the Detection, Diagnosis and Initial Treatment of Psoriatic ArthritisRelease Date:Review Process:Improving the Identification and Management of Patients with Atrial Fibrillation (AF) and venous thromboembolism (VTE)Release Date:Review Process:Medication Optimization in Primary CareRelease Date:Review Process:Quality Improvement Activities to Prevent Fatal Pulmonary ThromboembolismRelease Date:Review Process:Increasing Rates of BRCA Testing in Patients with Breast CancerRelease Date:Review Process: